Annals and Chronicles: Pediatric oncology in Amsterdam

Medical and Pediatric Oncology

Volumn 35, Issue 3, 2000, Pages 159-162

  Coppes Zantinga, Arty R ^a   Coppes, Max J ^b  

^a ALBERTA CHILDREN'S HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHILD; HUMAN; NETHERLANDS; ONCOLOGY; PEDIATRICS;

CHILD; HUMANS; MEDICAL ONCOLOGY; NETHERLANDS; PEDIATRICS;

EID: 0034267995     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-911x(200009)35:3<159::aid-mpo1>3.0.co;2-9     Document Type: Article

References (9)

1. Caron H, van Sluis P, van Hoeve M, et al. Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification. Nature Genet 1993;4: 187-190.
2. Caron H, van Sluis P, de Kraker J, et al. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma. N Engl J Med 1996;334:225-230.
3. Pieters R, Huismans DR, Loonen AH, et al. Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia. Lancet 1991;338:399-403.
4. Kaspers GJL, Pieters R, Veerman APJ. Drug resistance in leukemia and lymphoma III. New York: Kleuver Academic/Plenum Publishers; 1999.
5. Wijsenbeek T. Zieke lieverdjes. Amsterdam: Ploegsma; 1990.
6. Allanson JE, Hennekam RC, Ireland M. De Lange syndrome: subjective and objective comparison of the classical and mild phenotypes. J Med Genet 1997;34:645-650.
7. Smith M, Herrell S, Lusher M, et al. Genomic organisation of the human chordin gene and mutation screening of candidate Cornelia de Lange syndrome genes. Hum Genet 1999;105:104-111.
8. van Herk R. Een schepping uit het niets. Amsterdam: Ten Brink Meppel b.v.; 1991.
9. Pinedo HM, Giaccone G. P-glycoprotein - a marker of cancer-cell behavior. N Engl J Med 1995;333:1417-1419.